「Discovery, Development, and Current Status of Canagliflozin, an SGLT2 inhibitor」
Kenji Arakawa, Ph. D.
Senior Manager
Research Planning & Publication Group 2 Medical Intelligence Department
Ikuyaku, Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation
Date/Time：January 15, 2021 16:00 ～ 17:00
To be held Online
Poster here　→　荒川先生セミナーポスター01152021英語版（改）zoom only